Thales Kronenberger - Concepedia

Author

Thales Kronenberger

University of Eastern Finland ORCID

Also Known As

Ferreira, Glaucio Monteiro, Kronenberger, T., Kronenberger, Thales, T. Kronenberger, Thales Kronenberger

189

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Eastern Finland University of Tübingen University Children's Hospital Tübingen Universidade Federal de Minas Gerais Universidade de São Paulo

About

Thales Kronenberger is an author at University of Eastern Finland specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	18	361
2	Biochemistry	11	11	174
3	Natural Sciences	9	9	138
4	Engineering	1	1	12
5	Biomolecular Engineering	1	1	18

Thales Kronenberger

Publications

951

Citations

H-Index

Page 1

	Year	Citations
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination Thanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, Journal of Medicinal Chemistry	2022	66
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer Ramona Rudalska, Jule Harbig, Marteinn T. Snaebjornsson, Nature Cancer OncologyMedicineLiver PhysiologyPathologyHepatotoxicity	2021	54
Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease M <sup>pro</sup> and Papain-like Protease PL <sup>pro</sup> of SARS-CoV-2 Lucianna Helene Santos, Thales Kronenberger, Renata G. Almeida, Journal of Chemical Information and Modeling	2022	40
Structure-Based Design of Selective Salt-Inducible Kinase Inhibitors Roberta Tesch, Marcel Rak, Monika Raab, Journal of Medicinal Chemistry	2021	39
HQSAR and random forest-based QSAR models for anti-T. vaginalis activities of nitroimidazoles derivatives Gabriel Corrêa Veríssimo, Evaldo Francisco Menezes Dutra, Anna Letícia Teotonio Dias, Journal of Molecular Graphics and Modelling Medicinal ChemistryDrug TargetMedicineRational Drug DesignForest-based Qsar Models	2019	37
Preclinical toxicity of innovative molecules: In vitro, in vivo and metabolism prediction Daniela Rodrigues Tonholo, Vinícius Gonçalves Maltarollo, Thales Kronenberger, Chemico-Biological Interactions Preclinical Drug EvaluationBiochemistryPredictive ToxicologyMedicineInnovative Molecules	2019	35
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): A study protocol Jéssica Bassani Borges, Victor Fernandes de Oliveira, Gláucio Monteiro Ferreira, Research in Social and Administrative Pharmacy Genome-wide Association StudyMetabolic SyndromeFamilial HypercholesterolemiaStudy ProtocolGenetics	2020	33
Antibacterial activity of synthetic 1,3‐bis(aryloxy)propan‐2‐amines against Gram‐positive bacteria Mateus Sá Magalhães Serafim, Stefânia Neiva Lavorato, Thales Kronenberger, MicrobiologyOpen	2019	29
Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer Carine M. Abdelmalek, Zexi Hu, Thales Kronenberger, Journal of Medicinal Chemistry	2022	27
SARS-COV-2 M<sup>pro</sup> conformational changes induced by covalently bound ligands Gláucio Monteiro Ferreira, Thales Kronenberger, Arun Kumar Tonduru, Journal of Biomolecular Structure and Dynamics	2021	26

Page 1